INNOVENT BIO

01801

----

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: INNOVENT BIO(01801) the Revenue is 9.954 B (+52.67%), Miss estimate;the EBIT is 1.273 B (+56.6%), Beat estimate;the EPS is 0.809 (--%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

9.95B52.67%

11.36B74.26%

-1.41B21.59%

EBITExceed expectations

1.27B56.60%

1.26B54.97%

+0.01B1.63%

EPSExceed expectations

0.8085--

0.5429--

+0.2656--%

Upcoming earnings report - Q3 FY2026

Available dateNov 25, 2026

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: HKD

Quarterly

EBIT

ActualEstimateUnit: HKD

Quarterly

Net income

ActualEstimateUnit: HKD

Quarterly

EPS

ActualEstimateUnit: HKD

Quarterly